| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |